Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Search

Emily Cowley Leongini’s Insights

137 total results. Page 11 of 12.

Alerts
USDA and FDA Issue Proposals to Regulate Genome Edited Plants, Animals, and Microorganisms
January 19, 2017
News
Kirsten Hart and Emily Leongini Co-Author Article on Cannabis Issues in LA Business Journal
December 21, 2016
Health Care Counsel Blog
US Attorney Announces Kickback and False Claims Act Settlement with Device Manufacturer BioTelmetry/MedNet
November 29, 2016
Health Care Counsel Blog
FDA Issues Final Version of Guidance for Industry, Contract Manufacturing Arrangements for Drugs: Quality Agreements
November 28, 2016
Health Care Counsel Blog
FDA Announcement on Guidance for Industry, Generic Drug User Fee Amendments of 2012
November 22, 2016
Alerts
Travels in Canada — 2017: The Year of the “Big Mess”
October 27, 2016
Health Care Counsel Blog
Mylan Agrees to $465 Million Settlement with DOJ Over EpiPen Medicaid Drug Rebate Reporting Classification
October 11, 2016
Alerts
DEA Denies Marijuana Rescheduling Petition, Eases Research Restrictions
August 16, 2016
Alerts
Legislation Introduced in Congress to Ease Medical Marijuana Restrictions
June 28, 2016
Alerts
FDA to Reevaluate ‘Healthy’ Food Claims
May 13, 2016
Alerts
DEA Approves Medical Marijuana Clinical Trial
May 6, 2016
Alerts
DEA Considers Rescheduling Marijuana
April 18, 2016

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Current page 11
  • Page 12
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

Back to Top